Mar 29, 2019
Multiple Myeloma Day Multiple Myeloma is relatively a rare disease. It accounts for approximately 1% of all cancers and 10% of all blood and bone marrow cancers. For more information on Multiple Myeloma.
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper